HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Murat Mert Atmaca Selected Research

Multiple Sclerosis

3/2021The First Cure Experience of A Clinic: Approach to The Patient to Start Ocrelizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Murat Mert Atmaca Research Topics

Disease

3Ischemic Stroke
11/2023 - 01/2020
3Epilepsia Partialis Continua
01/2018 - 08/2015
3Status Epilepticus (Complex Partial Status Epilepticus)
12/2017 - 08/2015
2Epilepsy (Aura)
01/2018 - 12/2017
1Stroke (Strokes)
11/2023
1Infections
11/2022
1COVID-19
11/2022
1Transthyretin-Related Hereditary Amyloidosis
01/2022
1Multiple Sclerosis
03/2021
1Hemorrhage
01/2020
1Seizures (Absence Seizure)
09/2018
1Double cortex
12/2017
1Neoplasms (Cancer)
12/2017
1Autoimmune Diseases of the Nervous System
12/2017

Drug/Important Bio-Agent (IBA)

3erucylphosphocholineIBA
01/2018 - 08/2015
2AntibodiesIBA
11/2023 - 12/2017
2ocrelizumabIBA
11/2022 - 03/2021
2Levetiracetam (Keppra)FDA LinkGeneric
10/2017 - 08/2015
1Prealbumin (Transthyretin)IBA
01/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
09/2018
1Natalizumab (Tysabri)FDA Link
09/2018
1N-Methylaspartate (NMDA)IBA
12/2017
1gamma-Aminobutyric Acid (GABA)IBA
12/2017
1AutoantibodiesIBA
12/2017
1Phenytoin (Dilantin)FDA LinkGeneric
10/2017

Therapy/Procedure

2Therapeutics
11/2022 - 11/2021
1Duration of Therapy
11/2022
1Thrombolytic Therapy
01/2020